Deficient Immune Response following SARS-CoV-2 Vaccination in Patients with Hepatobiliary Carcinoma: A Forgotten, Vulnerable Group of Patients

INTRODUCTION: Data on immune response rates following vaccination for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in patients with hepatobiliary carcinoma (HBC) are rare. However, impaired immunogenicity must be expected due to the combination of chronic liver diseases (CLDs) with m...

Descripción completa

Detalles Bibliográficos
Autores principales: Monin, Malte B., Baier, Leona I., Gorny, Jens G., Berger, Moritz, Zhou, Taotao, Mahn, Robert, Sadeghlar, Farsaneh, Möhring, Christian, Boesecke, Christoph, van Bremen, Kathrin, Rockstroh, Jürgen K., Strassburg, Christian P., Eis-Hübinger, Anna-Maria, Schmid, Matthias, Gonzalez-Carmona, Maria A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601882/
https://www.ncbi.nlm.nih.gov/pubmed/37901199
http://dx.doi.org/10.1159/000529608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601882/
https://www.ncbi.nlm.nih.gov/pubmed/37901199
http://dx.doi.org/10.1159/000529608

Ejemplares similares